We are happy to invite you to our next webinar! Innovation in probiotics by our expert Dr. Iris Hardewig Date: 15th of November 2018 Time: 3:00pm (CET) – 30 min talk and 15 min Q&A Probiotics no longer target just the immune system and/or gut health. Recent research shows that probiotics and prebiotics as well [...]
a&r’s News Digest – We dedicate this month’s issue to Italy’s new Decree on botanicals and the first EU authorized 14.1 health claim for a combination product. Also, meet Infarm, this month’s startup. […]
There has been plenty of discussions around maximum levels of vitamins and minerals allowed in food supplements in Europe. The Directive 2002/46/EC on food supplements envisages the setting of maximum and minimum amounts of vitamins and minerals in supplements however the Commission has not yet taken any action. Hence, national bodies have taken matters [...]
Earlier this month, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) reclassified certain glucosamine products as medicines. According to the MHRA statement, products containing doses equal to or greater than 1178 mg per day of base glucosamine (equivalent to 1500 mg glucosamine sulphate) can no longer be classified as food supplements and are [...]
a&r’s News Digest – We dedicate this month’s issue to regulatory news about the UK reclassification of glucosamine products and new maximum levels of vitamin B6 in Food Supplements in The Netherlands. A special space for Innovation will now have a dedicated section on our newsletter. In this issue, [...]
Following last year's French Decree backing the voluntary adoption of “Nutri-Score”, now it is time for Belgium to follow the same footsteps. A nutrition declaration is already mandatory in the EU in prepacked foods or products containing nutritional and/or health claims. This nutrition labelling comprises detailed information on the energy value, the amounts of [...]
We are happy to invite you to our next webinar! Building Scientific Evidence to Support Nutrition & Health Claims by our expert Dr. Heike Stier Date: 27st of September 2018 Time: 3:00pm (GMT+2) – 30 min talk and 15 min Q&A In our next webinar we provide an overview of the current situation of the [...]
a&r’s News Digest – We dedicate this month’s issue to a&r next webinar, “Nutri-Score” labelling system and three new Novel Foods granted EU authorization. […]
Cannabis sativa L. is a plant with multiple faces. Industrial hemp was bred to contain very little tetrahydrocannabinol (THC). Under the premise that the THC content does not exceed 0.2 % of the plant and without prejudice to other national regulations, the plant and their parts are accepted food sources in the EU (Novel Food [...]
a&r’s News Digest – We dedicate this month’s issue to Cannabis and short regulatory news. […]
MeriCal, a contract manufacturer and packager of high quality probiotics and nutritional supplements, has recently signed a final commercial agreement to acquire Global Health Industries (GHI).
GHI is highly specialized in the manufacturing of probiotics. MeriCal’s acquisition of GHI will increase market competitiveness and will drive international expansion.
In September, color-ingredients manufacturer Roha (India) completed the acquisition of New Foods Industry S.p.A., an Italian company.
Roha is a leader in the color-ingredients market worldwide, and New Foods Industry is specialized in dry ingredients for the food and beverage industries.
This is the third acquisition for Roha during this year, enabling its further consolidation in the color business.
Relevium has signed a non-binding agreement to acquire an American nutraceutical e-brand that sell their products mainly through Amazon.
Relevium is a publicly traded company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness market. The value of this transaction is currently estimated at 1,15 mill EUR and it is foreseen to be closed on the 30th of November this year.
Last summer, Relevium completed the acquisition of BioGanix, another e-commerce brand and they have plans to conclude more transactions with e-retail brands in the future.
Frutarom licensed AB-FORTIS in 2012 and now is buying the patent. AB-Fortis is a micro-encapsulation system that allows delivering 100% of the recommended daily amount of iron in a single dose, with high bioavailability and no adverse effects in taste or during digestion. “AB-Fortis expands Frutarom’s diverse product portfolio in the growing field of specialty healthy ingredients,” says Dr Raimund C. Hoenes, General Manager of Frutarom Health. With this transaction, AB-BIOTICS will focus on its probiotics business, which represents 87% of its total sale. In addition, the sales of AB-FORTIS will support the great R&D investment that AB-BIOTICS has done to reinforce their current probiotics concepts.
Walgreens has announced that it will invest $416 million to acquire 40% stake in Sinopharm Holding GuoDa Drug Store Co., Ltd (GuoDa). Walgreens is the second-largest pharmacy store chain in the US behind CVS Health. GuoDa retails pharmaceutical and healthcare products across China.
Walgreens was already present in China through Alliance Boots. This new investment highlights the interest of Walgreens in the Chinese fast-paced retail pharmacy business.
Walgreens investment took place in the same week that CVS announced to spend $69 billion to buy Aetna, the third largest health insurer in the U.S. CVS also has international operations but has not revealed interest in China yet.
Earlier this month, Nestlé announced that it agreed to acquire Atrium Innovations (transaction to be completed Q1 2018). Atrium is globally recognized for the development, production, and commercialization of innovative and scientifically-proven natural health products. Its strategy is complementary with Nestlé science-based natural solutions for consumers and health care professionals. With this acquisition, Nestlé will extend its consumer healthcare nutrition portfolio, and Atrium will compete more effectively in the global market place.
A clear evidence that silos between industries will be breaking down in the future.
Global ingredients company DSM has acquired Biocare Copenhagen, expanding their gut health portfolio for an undisclosed price. With this acquisition, DSM will increase its gut health portfolio with probiotics. The company has showed interest in gut health ingredients beyond the well-known indications for digestive and immune health.
It has been reported by Bloomberg that Nestle is currently the top bidder for Merck KGaA’s, offering up to $5 billion. According to the sources, companies previously interested in this business have dropped out of the bidding, including Perrigo and Bain and Cinven, while Reckitt Benckiser and Mylan are still in the running. Nestle, frontrunner at the moment, has been strengthening its health business, and acquired Atrium Innovations for $2.3 billion last month.